Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Miravitlles

Showing results (41-50 of 564) with videos related to

Pageof 57
Sort By:
The European Respiratory Journal|July 2, 2014
Viral, bacterial or both? Regardless, we need to treat infection in COPDTobias Welte, Marc Miravitlles
Archivos De Bronconeumologia|March 21, 2018
Augmentation therapy for emphysema due to alpha-1 antitrypsin deficiency: ProMiriam Barrecheguren, Marc Miravitlles
European Respiratory Review : an Official Journal of the European Respiratory Society|June 6, 2020
Preventing readmissions of COPD patients: more prospective studies are neededAlexa Nuñez, Marc Miravitlles
The Lancet. Respiratory Medicine|October 25, 2019
Non-eosinophilic severe exacerbations of COPD: what about antibiotics?Marc Miravitlles, Carl Llor
Chest|March 10, 2004
No more equivalence trials for antibiotics in exacerbations of COPD, pleaseMarc Miravitlles, Antoni Torres
Expert Opinion on Pharmacotherapy|June 24, 2008
Moxifloxacin: a respiratory fluoroquinoloneMarc Miravitlles, Antonio Anzueto
The European Respiratory Journal|October 27, 2022
Cancer risk associated with alpha-1-antitrypsin deficiency: only large registries will give us the answerMiriam Barrecheguren, Marc Miravitlles
The American Journal of Medicine|January 7, 2018
The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPDAntonio Anzueto, Marc Miravitlles
Multidisciplinary Respiratory Medicine|September 11, 2012
The overlap phenotype: the (missing) link between asthma and COPDBarbara Piras, Marc Miravitlles
Chest|October 7, 2018
COUNTERPOINT: Should LAMA/LABA Combination Therapy Be Used as Initial Maintenance Treatment for COPD? NoMiriam Barrecheguren, Marc Miravitlles
Pageof 57

Showing results (41-50 of 564) with videos related to

Sort By:
Pageof 57
The European Respiratory Journal|July 2, 2014
Viral, bacterial or both? Regardless, we need to treat infection in COPDTobias Welte, Marc Miravitlles
Archivos De Bronconeumologia|March 21, 2018
Augmentation therapy for emphysema due to alpha-1 antitrypsin deficiency: ProMiriam Barrecheguren, Marc Miravitlles
European Respiratory Review : an Official Journal of the European Respiratory Society|June 6, 2020
Preventing readmissions of COPD patients: more prospective studies are neededAlexa Nuñez, Marc Miravitlles
The Lancet. Respiratory Medicine|October 25, 2019
Non-eosinophilic severe exacerbations of COPD: what about antibiotics?Marc Miravitlles, Carl Llor
Chest|March 10, 2004
No more equivalence trials for antibiotics in exacerbations of COPD, pleaseMarc Miravitlles, Antoni Torres
Expert Opinion on Pharmacotherapy|June 24, 2008
Moxifloxacin: a respiratory fluoroquinoloneMarc Miravitlles, Antonio Anzueto
The European Respiratory Journal|October 27, 2022
Cancer risk associated with alpha-1-antitrypsin deficiency: only large registries will give us the answerMiriam Barrecheguren, Marc Miravitlles
The American Journal of Medicine|January 7, 2018
The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPDAntonio Anzueto, Marc Miravitlles
Multidisciplinary Respiratory Medicine|September 11, 2012
The overlap phenotype: the (missing) link between asthma and COPDBarbara Piras, Marc Miravitlles
Chest|October 7, 2018
COUNTERPOINT: Should LAMA/LABA Combination Therapy Be Used as Initial Maintenance Treatment for COPD? NoMiriam Barrecheguren, Marc Miravitlles
Pageof 57